METABOLISMO ÓSEO, VASCULAR, ENFERMEDADES INFLAMATORIAS CRÓNICAS Y BIOMARCADORES
METOSEO
University of Texas Southwestern Medical Center
Dallas, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas Southwestern Medical Center (2)
2018
-
When metformin is not enough: Pros and cons of SGLT2 and DPP-4 inhibitors as a second line therapy
Diabetes/Metabolism Research and Reviews, Vol. 34, Núm. 4
2013
-
Amadori products promote cellular senescence activating insulin-like growth factor-1 receptor and down-regulating the antioxidant enzyme catalase
International Journal of Biochemistry and Cell Biology, Vol. 45, Núm. 7, pp. 1255-1264